News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meisner Lara
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2023 |
4
| Meisner Lara (Chief Legal Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 1,875 shares
@ $24.21, valued at
$45.4k
Sold 499 shares
@ $25.03, valued at
$12.5k
Sold 5,126 shares
@ $25.02, valued at
$128.3k
Exercised 1,875 options to buy
@ $14, valued at
$26.3k
Exercised 499 options to buy
@ $18.51, valued at
$9.2k
Exercised 5,126 options to buy
@ $18.51, valued at
$94.9k
|
|
| 03/10/2023 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 29,971 shares
@ $29.07, valued at
$871.3k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 6,843 shares
@ $35.66, valued at
$244k
Exercised 4,971 options to buy
@ $23.03, valued at
$114.5k
Exercised 1,872 options to buy
@ $14, valued at
$26.2k
|
|
| 12/19/2022 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 300 shares
@ $28.08, valued at
$8.4k
Sold 1,297 shares
@ $28.44, valued at
$36.9k
Exercised 300 options to buy
@ $23.03, valued at
$6.9k
Exercised 1,297 options to buy
@ $23.03, valued at
$29.9k
|
|
| 12/14/2022 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 600 shares
@ $28.05, valued at
$16.8k
Sold 15,656 shares
@ $28.12, valued at
$440.2k
Exercised 600 options to buy
@ $23.03, valued at
$13.8k
Exercised 15,656 options to buy
@ $23.03, valued at
$360.6k
|
|
| 11/16/2022 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 8,125 shares
@ $22.05, valued at
$179.2k
Exercised 8,125 options to buy
@ $14, valued at
$113.8k
|
|
|
|